Displaying drugs 51 - 75 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Obiltoxaximab | 148000.0 |  | A monoclonal antibody used for prophylaxis or treatment of inhalational anthrax. | Antibacterial monoclonal antibodies / Specific Immunoglobulins |
| Ipilimumab | 148000.0 C6572H10126N1734O2080S40 |  | A human cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody used to treat metastatic or unresectable melanoma. | Antibodies, Monoclonal |
| Tocilizumab | 148000.0 C6428H9976N1720O2018S42 |  | An interleukin-6 (IL-6) receptor antagonist used to treat Cytokine Release Syndrome (CRS), Systemic Juvenile Idiopathic Arthritis (sJIA), Giant Cell Arteritis (GCA), and Rheumatoid Arthritis (RA). | Interleukin Inhibitors |
| Pertuzumab | 148000.0 |  | An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. | Antibodies, Monoclonal / HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors |
| Anifrolumab | 148000.0 | | A monoclonal antibody that inhibits type 1 interferon receptors, indicated in the treatment of moderate to severe systemic lupus erythematosus. | Selective Immunosuppressants |
| Fremanezumab | 148000.0 |  | A humanized monoclonal antibody directed against human calcitonin-gene related peptide to prevent migraines. | Calcitonin Gene-Related Peptide (CGRP) Antagonists |
| Teprotumumab | 148000.0 | | A fully human monoclonal antibody directed against insulin-like growth factor-1 receptor for the treatment of thyroid eye disease. | Selective Immunosuppressants |
| Ravulizumab | 148000.0 C6430H9888N1696O2028S48 | | A monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis. | Selective Immunosuppressants |
| Isatuximab | 148000.0 | | A chimeric monoclonal antibody targeted against surface CD38 glycoproteins for the treatment of multiple myeloma in patients who have failed previous therapies. | CD38 (Clusters of Differentiation 38) inhibitors |
| Retifanlimab | 148000.0 C6456H9934N1702O2032S46 | | A PD-1–blocking antibody indicated for the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma. | PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Amivantamab | 148000.0 | | An EGF and MET receptor targeted antibody indicated in the treatment of non-small cell lung cancer with an EGFR 20 exon insertion mutation. | Antineoplastic Agents, Immunological |
| Relatlimab | 148000.0 C6472H9940O2026N1704S38 | | A monoclonal antibody targeted against LAG-3 which is used in combination with nivolumab for the treatment of unresectable or metastatic melanoma. | Immune Checkpoint Inhibitors |
| Rozanolixizumab | 148000.0 | | A humanized monoclonal antibody targeting the human neonatal Fc receptor (FcRn) used to treat generalized myasthenia gravis. | Immunosuppressive Agents |
| Reslizumab | 147000.0 |  | An IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults. | Anti-Asthmatic Agents / Interleukin-5 Antagonist |
| Belimumab | 147000.0 C6358H9904N1728O2010S44 |  | A B-lymphocyte stimulator (BLyS)-specific inhibitor used to treat systemic lupus erythematosus and active lupus nephritis as an add-on therapy. | Selective Immunosuppressants |
| Ublituximab | 147000.0 | | A low-fucose CD20-targeted monoclonal antibody used in the treatment of relapsing forms of multiple sclerosis. | Selective Immunosuppressants |
| Avelumab | 147000.0 C6374H9898N1694O2010S44 | | An anti-PD-L1 monoclonal antibody used to treat metastatic merkel cell carcinoma, metastatic urothelial carcinoma, or renal cell carcinoma. | Antibodies, Monoclonal / PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors |
| Tralokinumab | 147000.0 C6374H9822N1698O2014S44 | | A monoclonal antibody directed against interleukin-13 which is used in the treatment of moderate-to-severe atopic dermatitis in patients requiring systemic therapy. | Agents for Dermatitis, Excluding Corticosteroids |
| Galcanezumab | 147000.0 | | A calcitonin-gene related peptide antagonist used to prevent migraines and treat cluster headaches. | Calcitonin Gene-Related Peptide (CGRP) Antagonists / Calcitonin Gene-Related Peptide Receptor Antagonists |
| Talquetamab | 147000.0 C6410H9938N1716O2006S45 | | A bispecific antibody used to treat adults with relapsed or refractory multiple myeloma. | Amino Acids, Peptides, and Proteins / Antibodies, Monoclonal / Bispecific Monoclonal Antibodies / Blood Proteins / Immunoglobulins / Proteins / Serum Globulins |
| Sutimlimab | 147000.0 C6436H9934O2012N1700S46 | | A monoclonal antibody directed towards complement subunit C1s used to reduce the need for blood transfusion due to hemolysis in patients with cold agglutinin disease. | Selective Immunosuppressants |
| Tezepelumab | 147000.0 C6400H9844N1732O1992S52 | | A human monoclonal IgG2λ thymic stromal lymphopoietin (TSLP)-blocking antibody for add-on maintenance therapy in severe asthma. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Blood Proteins / Drugs for Obstructive Airway Diseases / Globulins / Immunoglobulins / Immunoproteins / Proteins / Serum Globulins / Thymic Stromal Lymphopoietin Blocker |
| Mirikizumab | 147000.0 | | An anti-IL-23 monoclonal antibody used as a second-line therapy for moderate-to-severe active ulcerative colitis. | Anti-Ulcer Agents / Gastrointestinal Agents |
| Golimumab | 146943.1937 C6530H10068N1752O2026S44 |  | A TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Dupilumab | 146896.9522 C6512H10066N1730O2052S46 | | A monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults. | Agents for Dermatitis, Excluding Corticosteroids |
Displaying drugs 51 - 75 of 406 in total